High Quality Content by WIKIPEDIA articles! XF-73 is an experimental drug candidate. It is an anti-microbial which works via weakening bacteria cell walls. It is a potential treatment for methicillin-resistant Staphylococcus aureus (MRSA) and possibly Clostridium difficile. It is being developed by Destiny Pharma Ltd.